March 29, 2020

Epigenetics Market is estimated to grow with a CAGR of 15.03% during the forecast period from 2018 to 2026

According to the latest market report published by Credence Research, Inc. “Epigenetics Market – Growth, Future Prospects, and Competitive Analysis, 2018 – 2026”, the global epigenetics market was valued at US$ 4.63 billion in 2017 and is expected to reach US$ 16.50 billion by 2026, increasing to CAGR by 15.03 per cent from 2018 to 2026.

Market Insights

Epigenetics is a relatively new science in the broader field of genetics, involving the study of the chemical modification of specific genes or gene-associated proteins. These epigenetic changes do not involve changes to the actual DNA sequence. For the purpose of the study, the epigenetics market is segmented into product types such as kits (ChiP-Seq kits, full genome amplification kits, 5-HMC and 5-MC kits for analysis and other epigenetics kits), reagents, enzymes (DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes), instruments and bioinformatics tools. Currently, demand for kits is the highest on the market and is expected to show the fastest growth in the market over the forecast period. Continuous advancement in the nature and precision of test kits, increasing prevalence of different diseases, wide availability of robust, easy-to-use and cost-effective kits, and increased use of epigenetic technologies in research laboratories are factors that catalyze overall market growth.

Browse Full Report Originally Published by Credence Research at

The global market for epigenetics is segmented by technologies such as DNA methylation, histone modification, and other techniques. DNA methylation is the most widely accepted technology as it has great potential in the field of personalized drug development and understanding of functional mechanisms in complex cases of the disease. Epigenetics are used in cancer, metabolic diseases, immune diseases, cardiovascular diseases and other areas. Cancer applications held the largest market share in the baseline year 2017, as epigenetic alterations are essential for cell transformation to cancer and have great potential for manipulation in cancer detection, prevention, and therapy.

North America is the current leader in the global epigenetics market and is expected to be dominant over the forecast period. Higher acceptance of newer technologies, huge investment in R&D and developed healthcare infrastructure are key factors contributing to the region’s dominance. On the other hand, Asia Pacific is projected to show the fastest growth in the market over the forecast period, mainly due to an increase in healthcare spending and the development of healthcare infrastructure. Significant CRO activities in hubs such as India also feature the rapid pace of the Asia-Pacific market.

Market Competition Assessment:

The epigenetics market is highly competitive owing to the presence of market players across geographies with investments in research activities. The market currently is dominated by few key manufacturers such as Abcam, Plc., Active Motif, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Diagenode, Inc., Illumina, Inc., Merck & Co., Inc., New England Biolabs Inc., Perkinelmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Zymo Research Corp., and others.

Access Free Sample Copy of Research Report:

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Report Scope by Segments

By Product Type

  • Kits   
    • ChiP-Seq Kits
    • Whole-Genome Amplification Kits
    • 5-HMC and 5-MC Analysis Kits
    • Other Epigenetics Kits
  • Reagents
  • Enzymes
    • DNA-Modifying Enzymes
    • Protein-Modifying Enzymes
    • RNA-Modifying Enzymes
  • Instruments
  • Bioinformatics Tools

By Application Type

  • Cancer
  • Metabolic Diseases
  • Immune Diseases
  • Cardiovascular Diseases
  • Others

By Technology Type

  • DNA Methylation
  • Histone Modification
  • Other Techniques 

By Geography Segment

  • North America (the U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, Japan, India, Rest of Asia Pacific)
  • Rest of World (Middle East & Africa (MEA), Latin America)

Access Free Sample Copy of Research Report:

Leave a Reply

Your email address will not be published. Required fields are marked *